Buy & Sell Five9 Inc (FIVN) – Five9 Inc Price Today
Aura AI Summary
Key Stats
- $1.66BMarket Cap
- TechnologySector
- -18.89%3M Drawdown
- $1.74BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 68 daysTypical Hold Time
Five9 Inc (FIVN) is currently valued at a market capitalization of $1.66B, with an enterprise value of $1.74B. Over the past 52 weeks, Five9 Inc has traded between a low of $13.61 and a high of $29.24, highlighting its annual price range. Over the past three months, Five9 Inc has recorded a drawdown of -18.89%, reflecting recent price volatility. On average, investors hold Five9 Inc for approximately 68 days, indicating typical investor behavior on the platform.
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Most Recent News
US government moves toward equity stakes in AI firms ahead of historic IPOs, reshaping investor ownership.
The US government is actively negotiating to take equity stakes in AI companies like OpenAI and Anthropic ahead of their planned IPOs, following a precedent set by its investment in Intel. This move aims to give the public a share in AI-driven growth...
Trulieve becomes first US cannabis stock listed on NYSE, signaling sector shift.
Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for m...
BIO-key flagged by Nasdaq for late 10-Q filing, risking its Nasdaq listing status.
BIO-key International, a leader in biometric authentication, received a Nasdaq notice for failing to file its quarterly 10-Q report on time for Q1 2026. Nasdaq's notice indicates the company's compliance with listing rules is under review, and a hear...
